Faroright CV 125mg/200mg Tablet is a combination antibiotic medication containing Faropenem (125mg) and Clavulanic Acid (200mg), designed to treat a variety of bacterial infections. Faropenem, a broad-spectrum penem antibiotic, works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing bacterial enzymes from breaking down Faropenem, thereby enhancing its efficacy against beta-lactamase producing resistant strains. This synergistic combination makes Faroright CV effective in managing infections caused by both gram-positive and gram-negative bacteria, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. The tablet is typically prescribed based on the severity and type of infection, and it is important to complete the full course as directed by a healthcare professional to prevent resistance development. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, which are generally mild and transient. Patients with a history of hypersensitivity to penems, penicillins, or beta-lactamase inhibitors should avoid this medication. Faroright CV should be used cautiously in individuals with liver or kidney impairment, and it is essential to inform the physician of any other medications being taken to avoid potential drug interactions.